What is RSV (Respiratory Syncytial Virus) or bronchiolitis?
MILLIONS of Brits have been urged to book a lifesaving new jab that offers 86 per cent protection against a killer lung infections, studies show.
“Trials have been conducted in people aged over 60 years of age, including those with underlying medical conditions, but the number of volunteers aged 80 or over was too small to be certain of the extent of benefit.that the effectiveness of vaccines in trials of younger and healthier people was replicated in those who were much frailer and older.
Persons aged 6 months to 64 years in a clinical risk group, as defined in the Green Book, including pregnant women'SIGNIFICANT STEP'
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
‘Helpless’ mum praises new vaccine on NHS after her baby caught deadly virusWhat is RSV (Respiratory Syncytial Virus) or bronchiolitis?
Read more »
Vaccinate NOW to avoid ‘tripledemic’ of viruses, warn NHS chiefs as millions offered new jabWhat is RSV (Respiratory Syncytial Virus) or bronchiolitis?
Read more »
See if you are eligible for free vaccines as 'tripledemic' of winter illness approachesBookings for millions of people to get their flu and COVID vaccines open today - find out if you're eligible to get the jabs, including for respiratory syncytial virus (RSV).
Read more »
Vaccine push amid Fears of a 'tripledemic' of Covid, flu, and RSVWinter 2024 could see a 'tripledemic' which could overwhelm the UK, so the NHS is urging those eligible for Covid and flu jabs to get vaccinated.
Read more »
Proof-of-concept study shows breath analysis can diagnose respiratory infectionsA proof-of-concept study promises the speedy diagnosis of lower respiratory tract infections through analysis of human breath. The work is published in PNAS Nexus.
Read more »
Study reveals impact of human breast milk on infant microbiome and respiratory healthHuman breast milk regulates a baby's mix of microbes, or microbiome, during the infant's first year of life. This in turn lowers the child's risk of developing asthma, a new study shows.
Read more »